ORACEA® Capsules are a once-daily oral therapy that delivers visible results
Before and After ORACEA Capsules in Clinical Trials
*Individual results may vary
A multicenter, outpatient, double-blind, placebo-controlled, parallel-group trial was conducted over 16 weeks to evaluate the safety and efficacy of ORACEA Capsules. A total of 251 rosacea patients (≥18 years of age with 10 to 40 papules and pustules and ≤2 nodules, plus an IGA score of 2 to 4) participated.
Many subjects taking ORACEA Capsules in clinical trials started to see improvements (reduction in inflammatory lesions) in as little as 3 weeks-and improvements continued through the full 16-week course of study.
ORACEA Capsules are different because they treat rosacea symptoms
from the inside out
ORACEA Capsules are an oral medication, so they treat inflammation below your skin-the true cause of rosacea-to reduce the bumps and blemishes you see developing on the surface.
The active ingredient in ORACEA Capsules is doxycycline, but unlike traditional antibiotic doses of doxycycline, the low-dose formulation of ORACEA Capsules does not work by killing bacteria; instead it reduces the bumps and blemishes of rosacea because of its anti-inflammatory properties. That's important because rosacea is a chronic inflammatory skin condition-not a bacterial infection. In clinical studies, ORACEA Capsules have not been shown to contribute to antibiotic resistance.
ORACEA Capsules are well tolerated
In clinical studies, side effects of ORACEA Capsules were mild to moderate. And in a 16-week study comparing the effects of ORACEA Capsules to the antibiotic doxycycline, subjects taking ORACEA Capsules had a lower incidence of unwanted gastrointestinal side effects than with doxycycline 100 mg (5% vs 26%).